How closely related is graft-vs-leukemia to donor/recipient disparity?

被引：6

作者：

Weisdorf, Daniel J. ^{[1
]}

机构：

[1] Univ Minnesota, Minneapolis, MN 55455 USA

来源：

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2010年 / 23卷 / 04期

关键词：

graft-vs-leukemia effect; GVL; graft-vs-host disease; GVHD; acute leukemia; human leukocyte antigen; HLA; mismatch; unrelated donor; cord blood; conditioning regimen; VERSUS-HOST-DISEASE; CELL TRANSPLANTATION; SEVERITY; RELAPSE; DONORS;

D O I：

10.1016/j.beha.2010.09.015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Graft-vs-host disease (GVHD) is an unwanted complication of stem cell transplant, but the graft-vs-leukemia (GVL) effect has been shown to positively affect outcomes. GVHD and GVL have similar but not identical alloreactivity, and GVL may be affected by the source of grafts, the preparative conditioning regimen, and donor genetic elements. Human leukocyte antigen (HLA) mismatch does not appear to augment the GVL effect, and increased GVHD does not necessarily lead to decreased relapse. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：525 / 528

页数：4

共 50 条

[31] Donor-Related Risk Factors and Preoperative Recipient-Related Risk Factors for Graft Failure
Yu, Alice L.
Kaiser, Michaela
Schaumberger, Markus
Messmer, Elisabeth
Kook, Daniel
Welge-Lussen, Ulrich
CORNEA, 2014, 33 (11) : 1149 - 1156
[32] High-Throughput Identification of Graft-Vs-Leukemia TCRs in AML Patient Samples after Allogeneic Stem Cell Transplantation
Tubo, Noah J.
Wang, Duncheng
He, Qiuming
Chen, Yibin
Ngai, Ho
Huang, Yanqing
Kerros, Celine
Mao, Xizeng
Liang, Shoudan
Shukla, Sachet
Cuesta, Arnau Peris
Bachireddy, Pavan
Montiel, Julio Alcantara
Alatrash, Gheath
Koppikar, Priya
Molldrem, Jeffrey J.
BLOOD, 2023, 142
[33] Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients
Chan, Edie Y.
Larson, Anne M.
Gernsheimer, Terry B.
Kowdley, Kris V.
Carithers, Robert L., Jr.
Reyes, Jorge D.
Perkins, James D.
LIVER TRANSPLANTATION, 2007, 13 (04) : 516 - 522
[34] The Effect of Donor- and Recipient-Related Factors on Corneal Graft Survival in Penetrating Keratoplasty
Gediz, Feyza
Yuksel, Bora
Kusbeci, Tuncay
Akmaz, Okan
Karti, Omer
SEMINARS IN OPHTHALMOLOGY, 2019, 34 (01) : 11 - 18
[35] Long-term persistence but lack of graft-vs-leukemia efficacy of cord blood cells after secondary haploidentical hematopoietic cell transplantation
Russkamp, N. F.
Schanz, U.
Mueller, A. M. S.
BONE MARROW TRANSPLANTATION, 2016, 51 : S447 - S447
[36] Living Donor Liver Transplantation and Donor Graft Size: How Small Can We Go to Reduce Risk to the Donor and What is the Cost to the Recipient?
Mulligan, David
LIVER TRANSPLANTATION, 2009, 15 (11) : 1392 - 1394
[37] Superior graft-vs-leukemia effects after transplantation of murine allogeneic peripheral blood progenitor cells (PBPC) as compared to bone marrow.
Zeis, M
Uharek, L
Glass, B
Steinmann, J
Dreger, P
Schmitz, N
BLOOD, 1996, 88 (10) : 970 - 970
[38] Graft-vs-leukemia (GVL) activity induced by MHC-mismatched activated natural killer cells given after bone marrow transplantation.
Glass, B
Uharek, L
Zeis, M
Steinmann, J
Gassmann, W
Schmitz, N
BLOOD, 1995, 86 (10) : 2292 - 2292
[39] Cold ischemic injury and donor-recipient MHC disparity significantly increase post-transplant cardiac graft coronary arteriosclerosis
Soukiasian, HJ
Wong, A
Czer, L
Lefor, A
Nishi, G
Chopra, R
Raissi, S
Fontana, G
Demetriou, AA
Trento, A
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 199 (03) : S25 - S25
[40] Strong graft-vs-leukemia (GVL) effects of IL-2 activated natural killer cells given after bone marrow transplantation.
Zeis, M
Uharek, L
Glass, B
Dreger, P
Steinmann, J
Gassmann, W
Schmitz, N
EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 353 - 353

← 1 2 3 4 5 →